Compare Immunovant Inc. Common Stock (IMVT) vs Zeta Global Holdings Corp (ZETA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Zeta Global Holdings Corp — how do they compare? Immunovant Inc. Common Stock trades at $30.53 (market cap $6.25B), while Zeta Global Holdings Corp trades at $33.61 (market cap $8.29B). The key difference: Zeta Global Holdings Corp is the larger of the two by market cap, and Zeta Global Holdings Corp is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Zeta Global Holdings Corp for 18 Days on average.
| IMVT | ZETA | |
|---|---|---|
Market Cap | $6.25B | $8.29B |
Volume | 1,755,411 | 7,156,795 |
Sector | Health | Technology |
52-Week High | $44.96 | $33.74 |
52-Week Low | $17.03 | $14.55 |
Typical Hold Time | 0 Days | 18 Days |
Enterprise Value | $5.35B | $8.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ZETA trades at $33.74, showing strong technical momentum with a bullish moving average signal and trading near resistance at $34. The company demonstrates solid revenue growth with Q2 2026 revenue reaching $1.6B and has beaten earnings estimates for three consecutive quarters. Recent expansion into the UK market and AI platform adoption are driving investor optimism, though negative net margins and high valuation multiples warrant caution.
ZETA presents a growth opportunity with strong analyst support (75% buy ratings) and AI-driven business expansion, but faces execution risks from negative profitability and elevated valuation metrics. The stock's current price above the $32.40 consensus target suggests near-term consolidation potential amid ongoing business transformation efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Zeta Global Holdings Corp
Zeta Global is a leading data-driven marketing technology company that provides an omnichannel AI Marketing Cloud. By leveraging a proprietary data cloud of over 2.4 billion deterministic identities, it enables enterprise brands to acquire, grow, and retain customers through predictive intelligence and automated, agentic workflows.
Read more on ZETA →
